RxDoctor Payments Data

Katherine Coerver, MD

Behavioral Neurology & Neuropsychiatry · Centennial, CONPI 1831161157

Payments from drug & device makers

$245,547in general payments, 2019–2025

Across 835 payments — averaging $294.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$205K
  • Eisai Inc.$21K
  • AbbVie$3K
  • Biogen$2K
  • GE HealthCare$1K
  • Sage Therapeutics, LLC$1K
  • plus $12K from 54 others

What the payments were for

  • Consulting fees$6,36816%
  • Speaking & faculty fees$14,29035%
  • Travel & lodging$2,9037%
  • Food & beverage$17,00742%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly4$204,980
Eisai Inc.43$21,054
AbbVie(2 entities)190$3,035
Biogen20$2,441
GE HealthCare10$1,198
Sage Therapeutics, LLC8$1,123
Lilly USA, LLC38$957
UCB, Inc.37$937
Sanofi39$911
Lundbeck LLC37$781
Teva Pharmaceuticals USA, Inc.49$698
Amgen35$672
Neurocrine Biosciences, Inc.33$549
Bristol Myers Squibb13$529
Pfizer30$429
SK Life Science, Inc.15$388
Novartis26$328
Argenx US, Inc.16$310
Axsome Therapeutics, Inc.8$259
EMD Serono, Inc.12$258
Biohaven Pharmaceutical Holding Company Ltd.13$235
AstraZeneca10$205
Jazz Pharmaceuticals Inc.8$195
Acadia Pharmaceuticals Inc9$179
Johnson & Johnson6$175
Neurelis, Inc.7$170
Otsuka America Pharmaceutical, Inc.4$166
Bausch Health US, LLC8$159
Novo Nordisk2$146
Amneal Pharmaceuticals LLC9$145
Impel Pharmaceuticals Inc.3$143
CSL Behring5$117
Upsher-smith Laboratories LLC5$112
Medtronic(2 entities)5$112
MDD US Operations, LLC4$104
Tanabe Pharma America, Inc.5$88
Greenwich Biosciences, Inc.3$87
Supernus Pharmaceuticals, Inc.5$85
Adamas Pharmaceuticals, Inc.4$80
Avanir Pharmaceuticals, Inc.4$79
Sunovion Pharmaceuticals Inc.7$78
Biohaven Pharmaceuticals, Inc.4$73
Mallinckrodt Hospital Products Inc.4$72
Kyowa Kirin, Inc.3$70
Genentech USA, Inc.3$62
Abbott3$61
Grifols USA, LLC3$52
Akcea Therapeutics, Inc.3$50
Zyla Life Sciences, Inc.3$43
Merz Pharmaceuticals, LLC2$39
Arbor Pharmaceuticals, Inc.2$37
Life Molecular Imaging Ltd2$36
Promius Pharma LLC2$35
Sumitomo Pharma America, Inc.2$31
Endo Pharmaceuticals Inc.2$28
Acorda Therapeutics, Inc1$28
Scilex Pharmaceuticals Inc.1$22
Assertio Therapeutics, Inc.1$22
Collegium Pharmaceutical, Inc.1$21
Mallinckrodt Enterprises LLC1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few behavioral neurology & neuropsychiatry providers in Coloradoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$190,711
Medicare patients
373
Services billed
1,976

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Memantine Hcl258$7,638
Rivastigmine24$6,351
Donepezil Hcl638$5,831
Dimethyl Fumarate19$3,986
Memantine Hcl ErMemantine Hcl37$3,069
Levetiracetam ErLevetiracetam27$2,522
DilantinPhenytoin Sodium Extended12$2,033
Ropinirole ErRopinirole Hcl11$1,850
Levetiracetam26$1,220
Escitalopram Oxalate130$1,145
Gabapentin45$961
Quetiapine Fumarate34$959
Divalproex Sodium ErDivalproex Sodium19$878
Carbidopa-LevodopaCarbidopa/Levodopa21$691
Lamotrigine13$656

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerDilantin$429$2,03312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few behavioral neurology & neuropsychiatry providers in Coloradoon file to place this against a meaningful peer group, so we don't.

Other behavioral neurology & neuropsychiatry in Centennial

Where these figures come from

Is this you, or does something look wrong? →